AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting AGFiQ US Market Neutral Anti-Beta Fund is a Sell.
AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) 20-Day exponential moving average is 19.69, making it a Buy.
AGFiQ US Market Neutral Anti-Beta Fund’s (BTAL) 50-Day exponential moving average is 19.77, making it a Sell.